Study S001993

Adjuvant Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events During the Up-titration Phase

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06431308
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 120
Start: 2025-01-30
Primary completion: 2026-02-01
Lead sponsor: Ariel University
Conditions: Obesity; Drug
Interventions: BEHAVIORAL:nutritional intervention
Results posted: FALSE

Registered primary outcomes

Gastrointestinal symptoms assessment [Baseline and at the end of the study period (20 weeks)]
Defecation texture [Baseline and at the end of the study period (20 weeks)]
Bowel Movement (BM) frequency [Baseline and at the end of the study period (20 weeks)]
Participants gastrointestinal symptoms report [Baseline, at the end of the study period (20 weeks) and weekly until 20 weeks (for subjective GI symptoms report only)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.